PARP1 and neoplasm: Indeed, PARP inhibitor monotherapy significantly suppressed tumor growth in mice bearing xenografts derived from parental PARP inhibitor-sensitive cells (Fig. 6e), but not cells with acquired resistance to PARP inhibitors (Fig. 6c,d).